Detecting HEK293 Residual DNA Contamination in Your Cell or Gene Therapy Products

doi:Cell & Gene Therapy Insights 2023; 9(10), –1131

Detecting HEK293 Residual DNA Contamination in Your Cell or Gene Therapy Products

Cell & Gene Therapy Insights 2023; 9(10), –1131

Published: 25 May 2023

Infographic

Cell and gene therapies begin their development with the help of a host cell line, but before the product can be administered to a patient, any trace of the host cell DNA must be removed to avoid oncogenic effects.

View pdf

View this infographic which highlights:
What is HEK293 residual DNA?;
Impact of HEK293 residual DNA contamination;
Traditional molecular detection methods;
Introducing ddPCR technology;
Have confidence in your testing with BIO-RAD solutions.

Detecting HEK293 Residual DNA Contamination in Your Cell or Gene Therapy Products

Cell & Gene Therapy Insights 2023; 9(10), –1131

Cell & Gene Therapy Insights 2023; 9(10), –1131

Cell and gene therapies begin their development with the help of a host cell line, but before the product can be administered to a patient, any trace of the host cell DNA must be removed to avoid oncogenic effects. ﻿﻿

Cell and gene therapies begin their development with the help of a host cell line, but before the product can be administered to a patient, any trace of the host cell DNA must be removed to avoid oncogenic effects.